Skip to main content

Table 1 Epidemiological characteristics of seven immunosuppressed patients with visceral leishmaniasis, 2009–2018, Norway

From: Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients

Case no

Sex

Age

Chronic underlying disease

Immunosuppressive treatment

Fever, splenomegaly, weight loss

Other clinical features and duration of symptoms at diagnosis

Travel history

Likely place of transmission

Patient 1

M

66

Rheumatoid arthritis,

MTX 17.5 mg/week for 7 years and adalimumab

Yes

6 months of constitutional symptoms and oesophageal candidiasis. A chronic skin ulcer acquired in Spain one year ago was diagnosed as CL. Then, a prednisolone course due to worsening of RA was followed by the clinical picture of VL

Recreational travel to Spain > one year ago

Spain

Patient 2

M

78

Psoriasis arthritis

MTX 20 mg/week for > 5 years and prednisolone

Yes

Weight loss over a year. While in Thailand, fever and asthenia developed hospitalization. Splenectomy was performed after 10 days in hospital due to intractable pancytopenia

Several recreational travels to Thailand the last year; the last five years to Spain. Professional travels to Pakistan, East Africa and India the last 20 years

Unknown

Patient 3

M

79

Rheumatoid arthritis

MTX12.5 mg/week for several years and prednisolone

Yes

6 weeks of constitutional symptoms, prior to VL diagnosis. 16 months after treatment, he fell sick from a testis B-cell lymphoma. He then had a relapse of VL, prior to cytostatic treatment

Recreational travels to Spain one year, to Turkey 8 years and to Italy, Spain, Portugal some 20 years ago, respectively

Unknown

Patient 4

M

57

Myelofibrosis

No

Yes

Salmonella gastroenteritis while in Tanzania. Admitted 2 months later with constitutional symptoms and increasing weight loss 5–15 kg.

Holiday house in Spain. Recreational travel to Tanzania 2 months ago

Spain

Patient 5

M

41

HIV

No

Yes

Constitutional symptoms and 15 kg weight loss the last two months. On admission he had oesophageal candidiasis; HIV and VL were diagnosed respectively. Relapse of VL after 3 months, CD4, 119/ml

Prior to 2010 he lived in Portugal. He then lived in South Africa 2010–12, in Cape Verde 2012–14; thereafter in Norway. Many recreational and profession travels in Spain.

Spain, Portugal

Patient 6

M

83

Rheumatoid arthritis

MTX 20 mg/week for 10 months, initially together with prednisolone, but last 6 months MTX alone

Yes

Admitted with constitutional symptoms, two weeks after returning from Spain. Extensive diagnostic work-up and progressive weight loss 4-13 kg until diagnosed VL

Recreational travel to Spain

Spain

Patient 7

F

46

Ulcerative colitis

Azathioprine and infliximab for 1.5 years – discontinued 6 and 8 months after symptoms respectively

Yes

Splenectomy on the suspicion of lymphoma

Recreational travels to Spain

Spain